Literature DB >> 16723694

Translating mighty mice into neuromuscular therapeutics: is bigger muscle better?

Eric P Hoffman1, Diana Escolar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16723694      PMCID： PMC1606609          DOI： 10.2353/ajpath.2006.060270

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  16 in total

1.  Calf muscle strength in humans.

Authors:  S W Trappe; T A Trappe; G A Lee; D L Costill
Journal:  Int J Sports Med       Date:  2001-04       Impact factor: 3.118

2.  The relationship between muscle cross-sectional area and strength in various isokinetic movements among soccer players.

Authors:  Kazumi Masuda; Nobuo Kikuhara; Hideyuki Takahashi; Kunio Yamanaka
Journal:  J Sports Sci       Date:  2003-10       Impact factor: 3.337

3.  Balancing muscle hypertrophy and atrophy.

Authors:  Eric P Hoffman; Gustavo A Nader
Journal:  Nat Med       Date:  2004-06       Impact factor: 53.440

4.  Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy.

Authors:  Stephanie A Parsons; Douglas P Millay; Michelle A Sargent; Elizabeth M McNally; Jeffery D Molkentin
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

5.  Genetic and environmental sources of variation in physical fitness.

Authors:  L Pérusse; G Lortie; C Leblanc; A Tremblay; G Thériault; C Bouchard
Journal:  Ann Hum Biol       Date:  1987 Sep-Oct       Impact factor: 1.533

6.  Functional improvement of dystrophic muscle by myostatin blockade.

Authors:  Sasha Bogdanovich; Thomas O B Krag; Elisabeth R Barton; Linda D Morris; Lisa-Anne Whittemore; Rexford S Ahima; Tejvir S Khurana
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

7.  Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.

Authors:  Kathryn R Wagner; Alexandra C McPherron; Nicole Winik; Se-Jin Lee
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

Review 8.  Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.

Authors:  David J Glass
Journal:  Nat Cell Biol       Date:  2003-02       Impact factor: 28.824

9.  Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin.

Authors:  Simona Iezzi; Monica Di Padova; Carlo Serra; Giuseppina Caretti; Cristiano Simone; Eric Maklan; Giulia Minetti; Po Zhao; Eric P Hoffman; Pier Lorenzo Puri; Vittorio Sartorelli
Journal:  Dev Cell       Date:  2004-05       Impact factor: 12.270

10.  Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.

Authors:  A A Hack; M Y Lam; L Cordier; D I Shoturma; C T Ly; M A Hadhazy; M R Hadhazy; H L Sweeney; E M McNally
Journal:  J Cell Sci       Date:  2000-07       Impact factor: 5.285
View more
  4 in total

Review 1.  High-content drug screening with engineered musculoskeletal tissues.

Authors:  Herman Vandenburgh
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

Review 2.  Drug discovery and development for rare genetic disorders.

Authors:  Wei Sun; Wei Zheng; Anton Simeonov
Journal:  Am J Med Genet A       Date:  2017-07-21       Impact factor: 2.802

3.  Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice.

Authors:  Hua Shen; Susan Grimston; Roberto Civitelli; Stavros Thomopoulos
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

Review 4.  S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase.

Authors:  Julie D Saba; Anabel S de la Garza-Rodea
Journal:  Biochim Biophys Acta       Date:  2012-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.